TY - JOUR
T1 - Identification of imaging selection patterns in acute ischemic stroke patients and the influence on treatment and clinical trial enrollment decision making
AU - Luby, Marie
AU - Warach, Steven J.
AU - Albers, Gregory W.
AU - Baron, Jean Claude
AU - Cognard, Christophe
AU - Dávalos, Antoni
AU - Donnan, Geoffrey A.
AU - Fiebach, Jochen B.
AU - Fiehler, Jens
AU - Hacke, Werner
AU - Lansberg, Maarten G.
AU - Liebeskind, David S.
AU - Mattle, Heinrich P.
AU - Oppenheim, Catherine
AU - Schellinger, Peter D.
AU - Wardlaw, Joanna M.
AU - Wintermark, Max
N1 - Publisher Copyright:
© 2016 World Stroke Organization.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Background and Purpose: For the STroke Imaging Research (STIR) and VISTA-Imaging InvestigatorsThe purpose of this study was to collect precise information on the typical imaging decisions given specific clinical acute stroke scenarios. Stroke centers worldwide were surveyed regarding typical imaging used to work up representative acute stroke patients, make treatment decisions, and willingness to enroll in clinical trials. Methods: STroke Imaging Research and Virtual International Stroke Trials Archive-Imaging circulated an online survey of clinical case vignettes through its website, the websites of national professional societies from multiple countries as well as through email distribution lists from STroke Imaging Research and participating societies. Survey responders were asked to select the typical imaging work-up for each clinical vignette presented. Actual images were not presented to the survey responders. Instead, the survey then displayed several types of imaging findings offered by the imaging strategy, and the responders selected the appropriate therapy and whether to enroll into a clinical trial considering time from onset, clinical presentation, and imaging findings. A follow-up survey focusing on 6 h from onset was conducted after the release of the positive endovascular trials. Results: We received 548 responses from 35 countries including 282 individual centers; 78% of the centers originating from Australia, Brazil, France, Germany, Spain, United Kingdom, and United States. The specific onset windows presented influenced the type of imaging work-up selected more than the clinical scenario. Magnetic Resonance Imaging usage (27-28%) was substantial, in particular for wake-up stroke. Following the release of the positive trials, selection of perfusion imaging significantly increased for imaging strategy. Conclusions: Usage of vascular or perfusion imaging by Computed Tomography or Magnetic Resonance Imaging beyond just parenchymal imaging was the primary work-up (62-87%) across all clinical vignettes and time windows. Perfusion imaging with Computed Tomography or Magnetic Resonance Imaging was associated with increased probability of enrollment into clinical trials for 0-3 h. Following the release of the positive endovascular trials, selection of endovascular only treatment for 6 h increased across all clinical vignettes.
AB - Background and Purpose: For the STroke Imaging Research (STIR) and VISTA-Imaging InvestigatorsThe purpose of this study was to collect precise information on the typical imaging decisions given specific clinical acute stroke scenarios. Stroke centers worldwide were surveyed regarding typical imaging used to work up representative acute stroke patients, make treatment decisions, and willingness to enroll in clinical trials. Methods: STroke Imaging Research and Virtual International Stroke Trials Archive-Imaging circulated an online survey of clinical case vignettes through its website, the websites of national professional societies from multiple countries as well as through email distribution lists from STroke Imaging Research and participating societies. Survey responders were asked to select the typical imaging work-up for each clinical vignette presented. Actual images were not presented to the survey responders. Instead, the survey then displayed several types of imaging findings offered by the imaging strategy, and the responders selected the appropriate therapy and whether to enroll into a clinical trial considering time from onset, clinical presentation, and imaging findings. A follow-up survey focusing on 6 h from onset was conducted after the release of the positive endovascular trials. Results: We received 548 responses from 35 countries including 282 individual centers; 78% of the centers originating from Australia, Brazil, France, Germany, Spain, United Kingdom, and United States. The specific onset windows presented influenced the type of imaging work-up selected more than the clinical scenario. Magnetic Resonance Imaging usage (27-28%) was substantial, in particular for wake-up stroke. Following the release of the positive trials, selection of perfusion imaging significantly increased for imaging strategy. Conclusions: Usage of vascular or perfusion imaging by Computed Tomography or Magnetic Resonance Imaging beyond just parenchymal imaging was the primary work-up (62-87%) across all clinical vignettes and time windows. Perfusion imaging with Computed Tomography or Magnetic Resonance Imaging was associated with increased probability of enrollment into clinical trials for 0-3 h. Following the release of the positive endovascular trials, selection of endovascular only treatment for 6 h increased across all clinical vignettes.
KW - Computed Tomography scan
KW - Magnetic Resonance Imaging
KW - clinical trial
KW - ischemic stroke
KW - stroke
KW - thrombolysis
UR - http://www.scopus.com/inward/record.url?scp=84955456085&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955456085&partnerID=8YFLogxK
U2 - 10.1177/1747493015616634
DO - 10.1177/1747493015616634
M3 - Article
C2 - 26783309
AN - SCOPUS:84955456085
SN - 1747-4930
VL - 11
SP - 180
EP - 190
JO - International Journal of Stroke
JF - International Journal of Stroke
IS - 2
ER -